{"id":881860,"date":"2025-09-04T07:26:45","date_gmt":"2025-09-04T11:26:45","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/"},"modified":"2025-09-04T07:26:45","modified_gmt":"2025-09-04T11:26:45","slug":"immunocore-to-present-at-upcoming-investor-conferences-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/","title":{"rendered":"Immunocore to present at upcoming investor conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">Immunocore to present at upcoming investor conferences<\/p>\n<p align=\"justify\">(OXFORDSHIRE, England &amp; CONSHOHOCKEN, Penn. &amp; GAITHERSBURG, Md., US, September 3, 2025) <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LJyQ9fGlG9Ii86kVNtr6ss6Vytl7LBxzqrW9EyiiXDTTQoSX8dHcMcEc79xSjl8T2R9MaNYnzvO5inEznAYus3MaGZSVrJrPj75xYvgxDoMzqaX_D0vYOPtKgYFZguhRBDvF2JONegQd04roxbO9v77xZljtA9a3XosGhbNkHRtpNgED1SaO0c8bLjDBXNFE\" rel=\"nofollow\" target=\"_blank\">Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d)<\/a>, a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced management will participate at the following conferences in September.<\/p>\n<p align=\"justify\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<strong>Cantor Global Healthcare Conference <\/strong><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat: Friday, September 5, 2025, at 8:35 a.m. EDT<\/p>\n<p align=\"justify\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<strong>H.C. Wainwright 27<\/strong><sup><strong>th<\/strong><\/sup><strong> Annual Global Investment Conference <\/strong><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01&#215;1 and small group meetings: Monday, September 8, 2025<\/p>\n<p align=\"justify\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<strong>Baird<\/strong><strong>2025 Global Healthcare Conference <\/strong><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat: Tuesday, September 9, 2025, at 10:15 a.m. EDT<\/p>\n<p align=\"justify\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<strong>Morgan Stanley 23<\/strong><sup><strong>rd<\/strong><\/sup><strong> Annual Global Healthcare Conference <\/strong><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat: Wednesday, September 10, 2025, at 1:50 p.m. EDT<\/p>\n<p align=\"justify\">Where relevant, the presentations will be webcast live and can be accessed by visiting \u2018Events &amp; Presentations\u2019, under \u2018Events\u2019, via the \u2018Investors\u2019 section of Immunocore\u2019s website at www.immunocore.com. Following the event, a replay of the presentations will be made available for a limited time.<\/p>\n<p align=\"justify\">About Immunocore<\/p>\n<p align=\"justify\">Immunocore is a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX \u2013 Immune mobilizing monoclonal TCRs Against X disease \u2013 designed to treat a broad range of diseases, including cancer, autoimmune diseases and infectious diseases. Leveraging its proprietary, flexible, off-the-shelf ImmTAX platform, Immunocore is developing a deep pipeline in multiple therapeutic areas, including numerous active clinical and pre-clinical programs\u200b in oncology, infectious diseases, and autoimmune diseases. The Company\u2019s most advanced oncology TCR therapeutic, KIMMTRAK, has been approved for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma in the United States, European Union, Canada, Australia, and the United Kingdom.<\/p>\n<p align=\"justify\">Contact Information<\/p>\n<p align=\"justify\">\n        <strong>Immunocore <\/strong>\n      <\/p>\n<p align=\"justify\">S\u00e9bastien Desprez, VP Communications<br \/>T: +44 (0) 7458030732<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GdISLU2XdxRM6SJ7SAcKI1xU07-0SNl26tpu8_C5gwlbc4G2CPLV1lRqwN4ayuV45LaNHqsS40Crsd28XjF98uNVOGaBv-ZID-UOnPXU_2vbIvNIWIe6EVGsYk_XdhvUDwD75COxyMdWjg1nd_zR5A==\" rel=\"nofollow\" target=\"_blank\"><u>sebastien.desprez@immunocore.com<\/u><\/a><br \/>Follow Immunocore on LinkedIn: @Immunocore<\/p>\n<p align=\"justify\">\n        <strong>Investor Relations<\/strong>\n      <\/p>\n<p align=\"justify\">Clayton Robertson \/ Morgan Warenius<br \/>T: +1 (215) 384-4781<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kPWSj-K4IqMvrkdTsEkmzIGjVLdvdk0iZXNNJBHOm-0SqMFeyOTlea3u6-qlvAYvu6mK8iUTVIizP2wq0PBrLzDpVzEgv9dmbLKmUw1uVlk=\" rel=\"nofollow\" target=\"_blank\"><u>ir@immunocore.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNjMwNSM0MDIyMDgyNzEjMjIwNjI1OA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/Yzg4YmMxZWYtNmFhNi00MTMwLTljZjUtZTY2NDVmMDM4YWZmLTEyMTc4MTEtMjAyNS0wOS0wNC1lbg==\/tiny\/Immunocore-Holdings-plc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England &amp; CONSHOHOCKEN, Penn. &amp; GAITHERSBURG, Md., US, September 3, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced management will participate at the following conferences in September. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Cantor Global Healthcare Conference \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat: Friday, September 5, 2025, at 8:35 a.m. EDT \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0H.C. Wainwright 27th Annual Global Investment Conference \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01&#215;1 and small group meetings: Monday, September 8, 2025 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Baird2025 Global Healthcare Conference \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat: Tuesday, September 9, 2025, at 10:15 a.m. EDT \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Morgan Stanley 23rd Annual Global Healthcare Conference \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat: Wednesday, September 10, 2025, at &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Immunocore to present at upcoming investor conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-881860","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Immunocore to present at upcoming investor conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunocore to present at upcoming investor conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England &amp; CONSHOHOCKEN, Penn. &amp; GAITHERSBURG, Md., US, September 3, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced management will participate at the following conferences in September. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Cantor Global Healthcare Conference \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat: Friday, September 5, 2025, at 8:35 a.m. EDT \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0H.C. Wainwright 27th Annual Global Investment Conference \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01&#215;1 and small group meetings: Monday, September 8, 2025 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Baird2025 Global Healthcare Conference \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat: Tuesday, September 9, 2025, at 10:15 a.m. EDT \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Morgan Stanley 23rd Annual Global Healthcare Conference \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat: Wednesday, September 10, 2025, at &hellip; Continue reading &quot;Immunocore to present at upcoming investor conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-04T11:26:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNjMwNSM0MDIyMDgyNzEjMjIwNjI1OA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Immunocore to present at upcoming investor conferences\",\"datePublished\":\"2025-09-04T11:26:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-3\\\/\"},\"wordCount\":309,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyNjMwNSM0MDIyMDgyNzEjMjIwNjI1OA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-3\\\/\",\"name\":\"Immunocore to present at upcoming investor conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyNjMwNSM0MDIyMDgyNzEjMjIwNjI1OA==\",\"datePublished\":\"2025-09-04T11:26:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyNjMwNSM0MDIyMDgyNzEjMjIwNjI1OA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyNjMwNSM0MDIyMDgyNzEjMjIwNjI1OA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Immunocore to present at upcoming investor conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immunocore to present at upcoming investor conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/","og_locale":"en_US","og_type":"article","og_title":"Immunocore to present at upcoming investor conferences - Market Newsdesk","og_description":"Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England &amp; CONSHOHOCKEN, Penn. &amp; GAITHERSBURG, Md., US, September 3, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced management will participate at the following conferences in September. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Cantor Global Healthcare Conference \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat: Friday, September 5, 2025, at 8:35 a.m. EDT \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0H.C. Wainwright 27th Annual Global Investment Conference \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01&#215;1 and small group meetings: Monday, September 8, 2025 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Baird2025 Global Healthcare Conference \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat: Tuesday, September 9, 2025, at 10:15 a.m. EDT \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Morgan Stanley 23rd Annual Global Healthcare Conference \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat: Wednesday, September 10, 2025, at &hellip; Continue reading \"Immunocore to present at upcoming investor conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/","og_site_name":"Market Newsdesk","article_published_time":"2025-09-04T11:26:45+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNjMwNSM0MDIyMDgyNzEjMjIwNjI1OA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Immunocore to present at upcoming investor conferences","datePublished":"2025-09-04T11:26:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/"},"wordCount":309,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNjMwNSM0MDIyMDgyNzEjMjIwNjI1OA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/","name":"Immunocore to present at upcoming investor conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNjMwNSM0MDIyMDgyNzEjMjIwNjI1OA==","datePublished":"2025-09-04T11:26:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNjMwNSM0MDIyMDgyNzEjMjIwNjI1OA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNjMwNSM0MDIyMDgyNzEjMjIwNjI1OA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Immunocore to present at upcoming investor conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/881860","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=881860"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/881860\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=881860"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=881860"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=881860"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}